Skip to main content
. Author manuscript; available in PMC: 2014 Jul 1.
Published in final edited form as: Cancer. 2013 Apr 12;119(13):2383–2390. doi: 10.1002/cncr.28089

Figure 1.

Figure 1

Total testosterone levels in crizotinib treated and non-crizotinib treated patients in relation to lower limit of normal (LLN) of assay used. NCTG non-crizotinib treated group; CTG2 crizotinib treated group 2; CTG 1 crizotinib treated group 1.